Loading clinical trials...
Loading clinical trials...
Prospective, Randomized, Placebo Controlled Trial of the Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Conditions
Interventions
Nitric Oxide 160 ppm
Locations
7
United States
* Entire USA* The sponsor will provide air transportation and housing to patients that are not located in the area of clinical trial sites. All trial sites can treat adults.
Garden Grove, California, United States
Children's Hospital of Los Angeles (Adults can be treated here) (Site No. 500)
Los Angeles, California, United States
Nationwide Children's Hospital (Adults can be treated here) (Site No. 600)
Columbus, Ohio, United States
Medical University of South Carolina (Site No. 200)
Charleston, South Carolina, United States
University of Washington Medical Center (Site No. 100)
Seattle, Washington, United States
Medical College of Wisconsin (Site No. 400)
Milwaukee, Wisconsin, United States
Start Date
February 22, 2017
Primary Completion Date
June 1, 2020
Completion Date
June 1, 2020
Last Updated
March 5, 2021
NCT02417740
NCT06616857
NCT02740868
NCT07108153
NCT07274631
NCT07303621
Lead Sponsor
Novoteris, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions